1. High individual variability in LDL-reductions after inclisiran administration in a "real-world setting". (3rd October 2022) Authors: Makhmudova, U; Schatz, U; Kassner, U; Axthelm, C; Rohn, B; Westhoff, T; Vogt, A; Scholl, M; Stach, K; Sinnig, D L; Stuerzebecher, P; Schulze, P C; Landmesser, U; Laufs, U; Weingaertner, O Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗